# A Pilot Study of Neoadjuvant Chemotherapy With or Without Camrelizumab for Locally Advanced Gastric Cancer

> **NCT05101616** · PHASE1,PHASE2 · SUSPENDED · sponsor: **Shanghai Minimally Invasive Surgery Center** · enrollment: 100 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** camrelizumab+chemotherapy
- **DRUG:** Chemotherapy

## Key facts

- **NCT ID:** NCT05101616
- **Lead sponsor:** Shanghai Minimally Invasive Surgery Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2022-07-01
- **Primary completion:** 2025-01-01
- **Final completion:** 2027-01-01
- **Target enrollment:** 100 (ESTIMATED)
- **Why stopped:** difficult in enrolling participants
- **Last updated:** 2024-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05101616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05101616, "A Pilot Study of Neoadjuvant Chemotherapy With or Without Camrelizumab for Locally Advanced Gastric Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05101616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*